Neurocentria’s lead compound MMFS-01 improves brain age
FREMONT: Neurocentria Inc., a clinical-stage biopharmaceutical company developing therapeutics to enhance brain function and correct…
FREMONT: Neurocentria Inc., a clinical-stage biopharmaceutical company developing therapeutics to enhance brain function and correct…